| 000 | 01855cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030444.0 | ||
| 008 | 110905s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.12.02.Ph.D.2010.Ya.S | ||
| 100 | 0 | _aYasser Mabrouk Abdelwahhab Bakr | |
| 245 | 1 | 0 |
_aStudy of the sensitivity of lung cancer cell lines to TRAIL - induced apoptosis / _cYasser Mabrouk Abdelwahhab Bakr ; Supervised Mervat Elsayed Mohammed , Abdelhady Ali Abdelwahhab , Nadia Mohammed Elguendy |
| 246 | 1 | 5 | _aدراسة حساسية خلايا أورام الرئة المزروعة معمليا إلى الموت المبرمج المستحث ببروتين الترايل |
| 260 |
_aCairo : _bYasser Mabrouk Abdelwahhab Bakr , _c2010 |
||
| 300 |
_a97 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biochemistry | ||
| 520 | _aTumor necrosis factor related apoptosis - inducing ligand (TRAIL) is an apoptogenic cytokine with great tumor specificity and has been recently considered as the magic bullet in the treatment of cancer . Recently , TRAIL - DR4 and TRAIL - DR5 directed monoclonal antibodies showed anti - tumor effect against a panel of non - small cell lung cancer (NSCLC) cell lines in vitro with different levels of sensitivity to TRAIL - induced apoptosis | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBcl - 2 and p53 | |
| 653 | 4 | _aNSCLC | |
| 653 | 4 | _aTRAIL | |
| 700 | 0 |
_aAbdelhady Ali Abdelwahhab , _eSupervisor |
|
| 700 | 0 |
_aMervat Elsayed Mohammed , _eSupervisor |
|
| 700 | 0 |
_aNadia Mohammed Elguendy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c35050 _d35050 |
||